While previous research has established a clear association between the pathogenesis of heart failure and the overexpression of MR and aquaporin-1, supported by relevant clinical studies, the mechanism through which the benefit of inhibitors of MR is still unclear for DCM [47,48]. The gene discussed is AQP1; the disease is heart failure.